17Jun/13

Yar'Adua died of irreversible brain damage – Oviemo, ex-military medical … – DailyPost Nigeria

Yar’Adua died of irreversible brain damage – Oviemo, ex-military medical
DailyPost Nigeria
Speaking further, the respected doctor noted that the late Head of State was “hypo-ventilating at the time and by the time he got to Saudi Arabia, he had suffered irreversible brain death.” “Because Nigerians believe in the god of mammon and that money 

and more »

17Jun/13

விபத்தில் சிக்கி மூளைச்சாவு: முதியவர் … – மாலை மலர்


http://www.tamilmurasu.org/

விபத்தில் சிக்கி மூளைச்சாவு: முதியவர்
மாலை மலர்
ஈரோடு மாவட்டம் சத்தியமங்கலத்தை சேர்ந்தவர் ரங்கசாமி கவுண்டர் (வயது 76). கடந்த சில நாட்களுக்கு முன்பு மோட்டார் சைக்கிளில் சென்று 
மூளை சாவு அடைந்த இன்ஜி. மாணவனின் உடல் http://www.tamilmurasu.org/

all 2 news articles »

17Jun/13

New EXTEND Analyses Evaluate Efficacy Of Single Agent PIXUVRI® In 3rd And … – Daily Markets

New EXTEND Analyses Evaluate Efficacy Of Single Agent PIXUVRI® In 3rd And
Daily Markets
Compared to physicians’ choice of other agents given as monotherapy, single agent PIXUVRI resulted in 30 percent of patients who had previously received rituximab achieving a complete or unconfirmed durable complete response lasting on average 9.5 

and more »

17Jun/13

New EXTEND Analyses Evaluate Efficacy of Single Agent PIXUVRI(R) in 3rd … – Wall Street Journal (press release)

New EXTEND Analyses Evaluate Efficacy of Single Agent PIXUVRI(R) in 3rd
Wall Street Journal (press release)
Compared to physicians’ choice of other agents given as monotherapy, single agent PIXUVRI resulted in 30 percent of patients who had previously received rituximab achieving a complete or unconfirmed durable complete response lasting on average 9.5 

and more »

17Jun/13

New EXTEND Analyses Evaluate Efficacy of Single Agent PIXUVRI in 3rd and … – MarketWatch (press release)

New EXTEND Analyses Evaluate Efficacy of Single Agent PIXUVRI in 3rd and
MarketWatch (press release)
Compared to physicians’ choice of other agents given as monotherapy, single agent PIXUVRI resulted in 30 percent of patients who had previously received rituximab achieving a complete or unconfirmed durable complete response lasting on average 9.5 

and more »

17Jun/13

New EXTEND Analyses Evaluate Efficacy of Single Agent PIXUVRI® in 3rd and … – PR Newswire (press release)

New EXTEND Analyses Evaluate Efficacy of Single Agent PIXUVRI® in 3rd and
PR Newswire (press release)
Compared to physicians’ choice of other agents given as monotherapy, single agent PIXUVRI resulted in 30 percent of patients who had previously received rituximab achieving a complete or unconfirmed durable complete response lasting on average 9.5 

and more »